5 New Drug Approvals the FDA Gave Top Priority
The U.S. Food and Drug Administration's made it clear that granting a priority review to an application isn't exactly the same thing as making an application's review a top priority.
Over the past five weeks, the agency stamped approvals on five new drugs months ahead of an already shortened schedule.
PDUFA = prescription drug user fee act; SCD = sickle cell disease. Data sources: Company and FDA press releases.
Source Fool.com
